Dose optimization of deuruxolitinib in adults with alopecia areata: A phase 2 randomized trial

Name: Dose optimization of deuruxolitinib in adults with alopecia areata: A phase 2 randomized trial
Creator: Brett King
Published: 2026-09-03T18:43:05.675Z
Keywords: Dermatology, Alopecia Areata

King, Brett; Kempers, Steven; Atanaskova Mesinkovska, Natasha; Mirmirani, Paradi; McMichael, Amy; Mackay-Wiggan, Julian; Makredes Senna, Maryanne; L. Roberts, Janet; Mostaghimi, Arash; Jarell, Abel; Daly, Bridget; Hamilton, Colleen; Cassella, James

doi:10.17632/7w7j84x77s.1

Dose optimization of deuruxolitinib in adults with alopecia areata: A phase 2 randomized trial

Published: 3 September 2026| Version 1 | DOI: 10.17632/7w7j84x77s.1

Contributors:

Brett King, Steven Kempers, Natasha Atanaskova Mesinkovska, Paradi Mirmirani, Amy McMichael, Julian Mackay-Wiggan, Maryanne Makredes Senna, Janet L. Roberts, Arash Mostaghimi, Abel Jarell, Bridget Daly, Colleen Hamilton, James Cassella

Description

Supplemental materials for the manuscript titled, "Dose optimization of deuruxolitinib in adults with alopecia areata: A phase 2 randomized trial," by Brett King, Steven Kempers, Natasha A. Mesinkovska, Paradi Mirmirani, Amy McMichael, Julian Mackay-Wiggan, Maryanne M. Senna, Janet L. Roberts, Arash Mostaghimi, Abel Jarell, Bridget Daly, Colleen Hamilton, and James Cassella in the Journal of the American Academy of Dermatology.

Dose optimization of deuruxolitinib in adults with alopecia areata: A phase 2 randomized trial

Description

Files

Categories

Licence